Search Results - "Sana, D"

Refine Results
  1. 1

    Radioimmunotherapy for the treatment of head and neck cancer by Karam, Sana D, MD, Raben, David, MD

    Published in The lancet oncology (01-08-2019)
    “…SummaryEvidence to date shows that immune checkpoint inhibitors have little benefit in most patients with head and neck squamous cell carcinoma (HNSCC)…”
    Get full text
    Journal Article
  2. 2

    Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment by Darragh, Laurel B, Oweida, Ayman J, Karam, Sana D

    Published in Frontiers in immunology (31-01-2019)
    “…Radiation therapy has been used for many years to treat tumors based on its DNA-damage-mediated ability to kill cells. More recently, RT has been shown to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Advances in the management of pancreatic cancer by Del Chiaro, Marco, Sugawara, Toshitaka, Karam, Sana D, Messersmith, Wells A

    Published in BMJ (Online) (13-12-2023)
    “…Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than other cancers. Multimodal…”
    Get more information
    Journal Article
  5. 5

    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies by Robin, Tyler P., Jones, Bernard L., Gordon, Oren M., Phan, Andy, Abbott, Diana, McDermott, Jessica D., Goddard, Julie A., Raben, David, Lanning, Ryan M., Karam, Sana D.

    Published in Cancer (15-08-2017)
    “…BACKGROUND Sinonasal malignancies are a rare and heterogeneous group of tumors for which there is a paucity of robust data with which to guide management…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer by Gadwa, Jacob, Karam, Sana D.

    “…The complement system consists of a collection of serum proteins that act as the main frontline effector arm of the innate immune system. Activation of…”
    Get full text
    Journal Article
  8. 8

    The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy by Piper, Miles, Mueller, Adam C., Karam, Sana D.

    Published in Molecular carcinogenesis (01-07-2020)
    “…Fibroblasts are a key component of the tumor microenvironment (TME) that can serve as a scaffold for tumor cell migration and augment the tumor's ability to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ethnic Disparities in Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer by Morgan, Rustain L, Karam, Sana D, Bradley, Cathy J

    “…Abstract Background Prior research demonstrated statistically significant racial disparities related to lung cancer treatment and outcomes. We examined…”
    Get full text
    Journal Article
  11. 11

    Amateur antigen‐presenting cells in the tumor microenvironment by Darragh, Laurel B., Karam, Sana D.

    Published in Molecular carcinogenesis (01-02-2022)
    “…Presentation of tumor antigens is a critical step in producing a robust antitumor immune response. Classically tumor antigens are thought to be presented to…”
    Get full text
    Journal Article
  12. 12

    Tuberculosis-Cancer Parallels in Immune Response Regulation by Bickett, Thomas E, Karam, Sana D

    “…and cancer are two diseases with proclivity for the development of resistance to the host immune system. Mechanisms behind resistance can be host derived or…”
    Get full text
    Journal Article
  13. 13

    STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer by Oweida, Ayman J, Darragh, Laurel, Phan, Andy, Binder, David, Bhatia, Shilpa, Mueller, Adam, Court, Benjamin Van, Milner, Dallin, Raben, David, Woessner, Richard, Heasley, Lynn, Nemenoff, Raphael, Clambey, Eric, Karam, Sana D

    “…Abstract Background Radioresistance represents a major problem in the treatment of head and neck cancer (HNC) patients. To improve response, understanding…”
    Get full text
    Journal Article
  14. 14

    Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer by Ding, Ding, Stokes, William, Eguchi, Megan, Hararah, Mohammad, Sumner, Whitney, Amini, Arya, Goddard, Julie, Somerset, Hilary, Bradley, Cathy, McDermott, Jessica, Raben, David, Karam, Sana D

    Published in JAMA otolaryngology-- head & neck surgery (01-01-2019)
    “…Oral cavity squamous cell carcinoma (OCSCC) is associated with often-delayed clinical diagnosis, poor prognosis, and expensive therapeutic approaches…”
    Get more information
    Journal Article
  15. 15

    Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base by Amini, Arya, Jasem, Jagar, Jones, Bernard L, Robin, Tyler P, McDermott, Jessica D, Bhatia, Shilpa, Raben, David, Jimeno, Antonio, Bowles, Daniel W, Karam, Sana D

    Published in Oral oncology (01-05-2016)
    “…Highlights • Multimodality treatment improves OS in HPV-positive stage III–IVB disease. • AJCC stage was poorly associated with survival in HPV-positive…”
    Get full text
    Journal Article
  16. 16

    Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study by Bauman, Julie E., Karam, Sana D., O'Brien, Cathy, Mak, Gabriel, Cho, Byoung Chul

    Published in Head & neck (01-05-2024)
    “…Background The Phase 1 CLOVER study (NCT03509012) assessed durvalumab in combination with concurrent chemoradiotherapy (cCRT) in patients with advanced solid…”
    Get full text
    Journal Article
  17. 17

    Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma by Oweida, Ayman, Lennon, Shelby, Calame, Dylan, Korpela, Sean, Bhatia, Shilpa, Sharma, Jaspreet, Graham, Caleb, Binder, David, Serkova, Natalie, Raben, David, Heasley, Lynn, Clambey, Eric, Nemenoff, Raphael, Karam, Sana D.

    Published in Oncoimmunology (03-10-2017)
    “…Immunotherapy clinical trials targeting the programmed-death ligand axis (PD-1/PD-L1) show that most head and neck squamous cell carcinoma (HNSCC) patients are…”
    Get full text
    Journal Article
  18. 18

    Measurement of mouse head and neck tumors by automated analysis of CBCT images by Van Court, Benjamin, Neupert, Brooke, Nguyen, Diemmy, Ross, Richard, Knitz, Michael W., Karam, Sana D.

    Published in Scientific reports (25-07-2023)
    “…Animal experiments are often used to determine effects of drugs and other biological conditions on cancer progression, but poor accuracy and reproducibility of…”
    Get full text
    Journal Article
  19. 19

    The dichotomy of regulatory B cells in cancer versus allergic disease by Dang, Melissa, Yu, Justin, Galant‐Swafford, Jessica, Karam, Sana D.

    Published in Molecular carcinogenesis (01-01-2024)
    “…Regulatory B cells (Bregs) are an immunosuppressive cell phenotype that affects the immune system by limiting the inflammatory cascade. Dysregulation of Bregs…”
    Get full text
    Journal Article
  20. 20

    Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma by Piper, Miles, Ross, Richard Blake, Hu, Junxiao, Watanabe, Shuichi, Knitz, Michael, Mehrotra, Sanjana, Shulick, Richard, Chiaro, Marco Del, Karam, Sana D.

    “…Curative intent treatment of pancreatic adenocarcinoma (PDAC) relies on surgical resection. Modern treatment protocols focus on optimizing neoadjuvant therapy…”
    Get full text
    Journal Article